Daily recap · 2026-11-03 close
Market recap: Tuesday, November 3, 2026
At the Tuesday, November 3, 2026 close, ShadowBook had 5 of 19 names IN and 13 OUT; 2 names changed between IN and OUT. The Scan Board showed 4 buy and 4 sell calls across its three scans.
ShadowBook board
- IN (5): TSLA, AMD, PLTR, META, ISRG.
- OUT (13): MSTR, GLW, NVDA, AVGO, MU, MRVL, TSM, GOOG, AMZN, COIN, HOOD, BE, CBRS.
- MU moved IN → OUT (close 855.10).
- CBRS moved IN → OUT (close 97.82).
- Closest OUT names to their buy trigger: AMZN close 250.69, trigger 255.16 (+1.8%); CBRS close 97.82, trigger 102.50 (+4.8%); HOOD close 85.68, trigger 81.58 (-4.8%).
Scan Board (22 stocks)
- TriEMA sell: ISRG, MSTR, PLTR.
- TriEMA close buy: AMZN.
- GLYPH buy: GLW.
- GLYPH close buy: NVDA, COIN, HOOD, GOOG, BE.
- TFlow buy: COIN, HOOD, GOOG.
- TFlow sell: TSLA.
- TFlow close buy: NVDA, MSTR, CRWV, SNDK, VST.
- TriEMA holding a long: TSLA.
News Lean (morning edition)
These are inferred near-term news outlooks, not live indicator signals or guaranteed price direction.
- Bullish lean · AMD: Shares are up about 3–4% premarket after Monday's 7.5% drop, ahead of Q3 results after today's close, where analysts expect about $13B revenue and roughly $1.95 EPS.
- Bullish lean · NVDA: Nvidia is up about 2.4% premarket as chip stocks rebound after four straight down sessions.
- Bullish lean · MU: Micron is up about 3.5–4% premarket, reversing part of Monday's steep memory selloff as chip stocks rebound.
- Bullish lean · BE: Barclays upgraded Bloom Energy to Overweight this morning (target trimmed to $289 from $316), citing customer deposits of $661M and demand ramping faster than expected.
- Bullish lean · SPCX: Shares are rebounding about 3–4% on reported talks to buy Boost Mobile and after Musk said SpaceX's AI capex efficiency is underestimated.
- Bearish lean · PLTR: Shares are down about 6–8% premarket even though Q3 revenue rose 96% to $2.31B and guidance was raised, because U.S. commercial contract-value growth slowed to 11% from 153%.
- Bearish lean · MRVL: BofA cut Marvell to Neutral (target $225 from $400) and TD Cowen to Hold (target $175 from $350) this morning over dilution and timing of the all-stock Lumentum deal.
- Bearish lean · TSM: TSMC fell 1.5% to NT$2,295 in Taipei today as the Taiex posted its 7th-largest point drop on the overnight U.S. tech selloff, after its ADRs fell 1.85%.
- Bearish lean · COIN: Coinbase is trading near 52-week lows around $137–139 as crypto sentiment sours, following Monday's Morgan Stanley downgrade to Underweight with a $120 target.
- Bearish lean · HOOD: Shares slipped about 1.4% after Cantor cut its target to $120, with Q3 crypto revenue down 55% to $120M offset only partly by $173M of event-contract revenue.
- Bearish lean · META: Meta turned lower premarket after launching a five-part U.S. dollar bond offering to fund its AI build-out, with a possible euro offering alongside.
- Neutral/mixed · MSTR: B. Riley cut its Strategy target to $180 from $195 on a lower bitcoin assumption but kept Buy, with bitcoin near $77,000 and CFO Andrew Kang leaving Nov 5.
- Neutral/mixed · TSLA: Reuters reports Tesla's China-made EV sales rose 10.3% year over year in October, while the stock is little changed premarket amid debate over a possible SpaceX merger vote.
- Neutral/mixed · GLW: The strong Q3 (core sales up 19%, Gen AI products more than doubling, Q4 guide of $5.2–5.3B) is still weighed against valuation worries; no fresh verified catalyst found.
- Neutral/mixed · AVGO: Broadcom is only edging higher premarket while other chipmakers bounce more strongly; no fresh verified catalyst found.
- Neutral/mixed · GOOG: Analysts are lowering search-ad growth estimates after Q3 search revenue rose 12% ($63.35B) versus about 14.8% expected, while Cloud nearly doubled; shares sit near 52-week lows.
- Neutral/mixed · AMZN: Amazon has arranged up to $80B of secured supplier financing for AI infrastructure after a quarter with a $34.8B free-cash-flow outflow, balancing the strong AWS outlook.
- Neutral/mixed · ISRG: Coverage still centers on slower U.S. procedure growth and planned 2027 instrument price cuts after the Oct 20 Q3 beat; no fresh verified catalyst found.
Research only, not investment advice. Everything on this page is generated by fixed rules from MystTrades' own end-of-day data for this date; it is not a recommendation to buy or sell anything.